The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.
about
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome.Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.The BRCA2 variant c.68-7 T>A is associated with breast cancer.Genetic factors influencing prostate cancer risk in Norwegian men.Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
P2860
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@en
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@nl
type
label
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@en
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@nl
prefLabel
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@en
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@nl
P2093
P2860
P356
P1476
The Norwegian PMS2 founder mut ...... h normal immunohistochemistry.
@en
P2093
Astrid Stormorken
Cecilie Heramb
Eli Marie Grindedal
Elin Røyset
Harald Aarset
Heidi Medvik
Inga Bjørnevoll
Lovise Mæhle
Pål Møller
Wenche Sjursen
P2860
P2888
P356
10.1186/1897-4287-12-12
P577
2014-04-21T00:00:00Z
P5875
P6179
1024733624